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Pathogenicity of four infectious bursal disease virus (IBDV) isolates 
was studied on specific-pathogen-free (SPF) chickens. Chickens inoculated 
with isolates 92/04, 94/B551 and 97/61 developed severe clinical 
manifestations with a high mortality ranging from 70-80%, whereas the 
94/273 isolate caused 10% mortality. However, regardless of the isolates, 
significant differences (p< 0.05) were noted in the bursal scoring lesions and 
bursa to body weight ratio index in the infected groups in comparison to the 
control groups. The isolate 94/273 had l imited and comparatively less 
haemorrhagic lesions in the bursal tissues. However, the presence of severe 
haemorrhagic lesions in the bursal tissues along with the non-bursal tissues 
(muscles, thymus, spleen and at the junction of proventriculus and gizzard) 
were found only in the 92/04, 97/61 and 94/B551 isolates. 
i i i 
The VP2 gene ( 1351 bp) of the isolates (92/04, 94/273 and 94/8551 )  was 
amplified and cloned and the sequences were compared with other 18DV 
strains. All the isolates have the unique amino acid residues at positions 
P222A, V2561, and L2941 as found in other vvlBDV strains. Restriction 
fragment length polymorphism (RFLP) and sequence analysis of the VP2 
hypervariable region also indicated that all the isolates can be classified as 
vvlBDV based on the presence of Ssp I and Taql sites at the nucleotide 
positions 1011 and 833, respectively. All the isolates except 94/273 also 
have a Styl site at nucleotide position 888. The absence of Styl site in this 
isolate is associated with amino acid substitution at 254 from G to S in 
variant strain. The 94/273 also has an amino acid substitution at 270 from A 
to E as found in apathogenic IBDV. Thus, this is a first report on the isolation 
of wlBDV with some genotypic characteristic of variant and apathogenic 
IBDV strains. The 94/B551 also has one amino acid substitution at position 
300 E to S, which is uncommon among other wlBDV isolates. Based on the 
RFLP analysis the Malaysian (92/04, 941273 and 97/61 )  and Bangladeshi 
(94/B551) isolates can be differentiated using the restriction enzymes Pstl, 
Mbol and Taql. The deduced VP2 amino acids encoded by 92/04 is 
identical to the wlBDV strains from Israel, Japan and UK, whereas the other 
isolates (94/273 and 94/B551 )  have one to three amino acid substitutions, 
indicating that the wlBDV is evolving. However, the phylogenetic analysis 
suggested that the isolates are very close to each other and all of them may 
have derived from same origin as the vvlBDV strains isolated from China, 
Japan and Europe. 
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Kepatogenan empat strain virus penyakit bursa berjangkit (IBDV) ke atas 
ayam bebas patogen khusus (SPF) telah dikaji. Ayam yang diinokulat 
dengan strain 92/04, 94/273 dan 97/61 menunjukkan manifestasi klinikal 
yang teruk dengan kadar kematian tinggi diantara 70-80%, manakala 
isolate 94/273 menyebabkan kematian 10%. Walau bagamanapun, tanpa 
mengambil kira strain, terdapat perbezaan yang ketara (p<0.05) dalam skor 
lesi bursa dan indek nisbah bursa kepada be rat badan bagi kumpulan 
terjangkit berbanding dengan kumpulan kawalan. Strain 94/273 mempunyai 
lesi hemoraj yang kurang dan terhad dalam tisu bursa. Walau 
bagamanapun, kehadiran lesi hemoraj yang teruk pada tisu bursa dan tisu 
bukan bursa (otot, timus, limpa dan pada persimpangan proventrikulus dan 
hempedal) dijumpai hanya dalam strain 92/04, 97/61 dan 94/B551. Gen 
VP2 (1351 bp) bagi strain (92/04, 941273 dan 94/B551) diamplifasi dan 
diklonkan dan jujukan tersebut dibandingkan dengan strain IBDV yang lain. 
Kesemua strain mempunyai residu asid amino pad a kedudukkan P222A, 
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V2561 dan L2941 sebagaimana yang dijumpai dalam strain vvlBDV lain. 
Analisa fragmen pembatasan polimorfoma (RFLP) dan jujukan bagi 
kawasan hiper boleh ubah VP2 juga menunjukkan bahawa kesemua strain 
boleh dikelaskan sebagai vvlBDV berdasarkan kehadiran tapak Ssp I dan 
Taql pada kedudukan nukleotid 1011 dan 833. Kesemua strain kecuali 
94/273 mempunyai tapak Styl pada kedudukan nukleotid 888. Ketiadaan 
tapak Styl dalam strain ini dikaitkan dengan penggantian asid amino pada 
254 daripada G kepada S dalam strain varian. Strain 94/273 juga 
mempunyai penggantian asid amino pada 270 daripada A kepada E 
sebagaimana yang dijumpai dalam IBDV bukan patogen. Oleh itu, ini 
merupakan laporan pertama ke atas pemencilan vvlBDV dengan 
sebahagian ciri genotip bagi strain IBDV varian dan bukan patogen. Strain 
94/B551 juga mempunyai satu penggantian asid amino pada kedudukkan 
300 E kepada S, yang mana jarang didapati di kalangan strain vvlBDV lain. 
Berdasarkan analisa RFLP, strain Malaysia (92/04, 94/273 dan 97/61) dan 
strain Bangladesh (94/B551) boleh dibezakan dengan menggunakan enzim 
pembatas Pstf, Mbal dan Taql. Asid amino VP2 yang dikodkan oleh 92/4 
adalah sama dengan strain wlBDV dari Israel, Jepun dan UK, manakala 
strain-strain lain (94/273 dan 9418551) rnernpunyai satu hingga tiga 
penggantian asid amino, menunjukkan bahawa wlBDV terlibat sedang 
berubah. Walan bagairnanapun analisa filogenesis mencadangkan bahawa 
strain-strain tersebut adalah sangat harnpir antara satu sarna lain dan 
kesemua strain mungkin datang dari asal yang sarna seperti strain wlBDV 
yang dipencilkan dari China, Jepun dan Eropah. 
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I nfectious bursal disease virus ( IBOV) is the aetiological agent of 
infectious bursal disease ( IBO) or Gumboro disease that causes significant 
losses to the poultry industries either by causing high mortal ity in an acute 
disease or as a consequence of immunosuppression in young chickens (3-6 
weeks old) (Lukert and Saif, 1 991 ; Van Oen Verg, 2000) . I nfection by IBOV 
causes destruction of lymphoid organs, especial ly B-Iymphocytes in  the 
bursa of Fabricius (Hirai et al. , 1 974; Saif, 1 99 1 ) . Two distinct serotypes of 
IBOV, designated serotype 1 and 2 have been identified (Jackwood and 
Saif, 1 987). The serotype 1 strains are pathogenic to chickens and vary in 
their virulence, whereas serotype 2 strains, isolated from turkeys, are 
apathogenic for both turkeys and chickens (Ismail et al. , 1 988; Jackwood et 
al. , 1 982 and McFerran et al. , 1 980) . Serotype 1 can be divided on the basis 
of virulence and antigenic variation into classical virulent strain ,  very virulent 
(vv) strain and antigenic variant strain (Brown et aI. , 1 994; Lasher and 
Shane, 1 994; Snyder, 1 990 and Zierenberg et al. , 2000) . 
I nfectious bursal disease is considered to be among the most costly 
infectious diseases affecting commercial poultry producers (Kibenge et al. , 
1 988c; Lasher and Shane, 1 994 and Shane et al. , 1 994). Economic losses 
2 
from ISD arise from direct mortality, a reduction in the performance of 
clinically i l l  birds, cost of control measures and increased carcass 
downgrades and condemnation due to gangrenous dermatitis, 
col isepticemia and air-saccul itis (Lasher and Shane, 1 994; Lukert and Saif, 
1 997) .  Virus-induced immunosuppression adds to these costs, in the form of 
vaccination fai lures and increased incidence or severity of bacterial ,  viral ,  
and parasitic diseases (Anderson et aI. , 1 977; Lasher and Shane, 1 994) . 
IBDVs are non-enveloped, icosahedral particles with a genome 
consisting of two segments (A and 8) of double-stranded (ds) RNA that are 
packed inside a single-shel led capsid of about 60 nm in diameter. Nucleotide 
sequence analysis shows that segment A (- 3.3 kb) has a long open reading 
frame (ORF) of 3036 bp in length and a short ORF of 435 bp (VP5) , which 
overlaps with the 5' end of the long ORF (Kibenge et al. ,  1 990) . The long 
ORF encodes the VP2-VP4-VP3 polyprotein ( 1 1 0-kDa) which is cleaved by 
auto-proteolysis into individual viral proteins (VP2 and VP3) (Azad et al. , 
1 985; Hudson et aI. , 1 986) . The shorter ORF has been shown to encode a 
sma l l cystine-rich 1 7  -kDa protein (Mundt et al., 1 995). Of the three viral 
proteins, VP2 and VP3 are the major viral structural proteins, whereas VP4 
is a minor protein involved in the processing of the precursor polyprotein 
(Dobos et al. , 1 979; Jagadish et aI. , 1 988) . The VP2 protein is exposed on 
the surface of the virion and contains strain-specific epitopes. In vitro 
expression of VP2 and its utilisation as an antigen revealed that VP2 is the 
